Healthcare entity

JBS USA

Company JBSAY

medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Alcon, the most common co-covered peer. They are better corroborated than the beat average, carrying 5 original sources each against 3.1 for the same window.

Last mentioned: Jun 17, 2026

Entity pulse

Recent coverage · JBS USA

1 story
6 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about JBS USA

medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Alcon, the most common co-covered peer. They are better corroborated than the beat average, carrying 5 original sources each against 3.1 for the same window. At 6, the average consequence score sits below the same-window beat average of 6.3. JBS USA appears in 1 tracked Healthcare story from March 17, 2026.

Stories tracked
1
Sources per story
5

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering JBS USA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Deal Termination

    Alcon and LENSAR announce the end of the merger agreement due to FTC opposition.

  2. FTC Investigation

    The FTC intensifies its review of the merger, focusing on the ophthalmic laser market.

  3. Merger Agreement

    Alcon and LENSAR enter into a definitive agreement for Alcon to acquire LENSAR.

Stories mentioning JBS USA 1

Medical Devices Negative

Alcon Abandons LENSAR Acquisition Following FTC Antitrust Challenges

Alcon has officially terminated its merger agreement with LENSAR, a leader in femtosecond laser technology, citing insurmountable opposition from the Federal Trade Commission (FTC). The collapse of the deal highlights increasing regulatory scrutiny over consolidation within the specialized medical device and ophthalmic surgery sectors.

5 sources

JBS USA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.